Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Starpharma Holdings Ltd (OTCQX International:SPHRY)

4.17
Delayed Data
As of Aug 28
 0.00 / 0.00%
Today’s Change
3.27
Today|||52-Week Range
6.77
-1.19%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues915.5K858.6K250.6K669.6K
 
 
 
 
 
Depreciation And Amortization1.2M1.1M1.0M1.0M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses16.0M6.8M17.4M19.1M
 
 
 
 
 
Research And Development12.6M3.6M14.0M16.4M
 
 
 
 
 
Total Operating Expenses17.2M7.8M18.5M20.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-16.3M-7.0M-18.2M-19.4M
 
 
 
 
 
Interest Expense On Debt8.3K9.2K6.4K4.2K
 
 
 
 
 
Other Expenses212.0K25.6K6.4K3.3K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-14.2M-5.3M-17.3M-18.7M
 
 
 
 
 
Income Taxes0.000.00-3.9M-2.9M
 
 
 
Net Income-14.2M-5.3M-13.4M-15.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS26.8M28.3M28.4M31.0M
 
 
 
 
 
Shares To Calculate EPS Diluted26.8M28.3M28.4M31.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.52-$0.20-$0.46-$0.50
 
 
 
 
 
EPS Diluted-$0.52-$0.20-$0.46-$0.50